Pharmaceutical Care for Premature Infants with Candida Albicans Infection of the Central Nervous System
DOI:
https://doi.org/10.12974/2311-8687.2023.11.15Keywords:
Clinical phamacists, Premature infant, Central nervous system, CandidaAbstract
Objective: To explore the role of clinical pharmacists in the treatment of clinical diseases by adjusting the treatment of Candida albicans infection in the central nervous system of a premature infant.
Methods: Clinical pharmacists participated in the treatment of one premature infant with Candida albicans infection of the central nervous system, and provided drug selection suggestions based on drug safety and pharmacokinetics.
Results: The doctor partially adopted the suggestions of clinical pharmacists, revised the medication plan, and the child received reasonable treatment.
Conclusion: Clinical pharmacists can make full use of pharmaceutical knowledge to serve the clinic and improve the level of rational drug use.
References
Okike, I.O., et al., Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004-11: an observational study. Lancet Infect Dis, 2014; 14(4): 301-7. https://doi.org/10.1016/S1473-3099(13)70332-3 DOI: https://doi.org/10.1016/S1473-3099(13)70332-3
Hale, K.A., et al., Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant. Br J Haematol, 2010; 149(2): 263-72. https://doi.org/10.1111/j.1365-2141.2009.08072.x DOI: https://doi.org/10.1111/j.1365-2141.2009.08072.x
Castagnola, E., et al., Fungal infections in children with cancer: a prospective, multicenter surveillance study. Pediatr Infect Dis J, 2006; 25(7): 634-9. https://doi.org/10.1097/01.inf.0000220256.69385.2e DOI: https://doi.org/10.1097/01.inf.0000220256.69385.2e
Wattier, R.L., et al., A Prospective, International Cohort Study of Invasive Mold Infections in Children. J Pediatric Infect Dis Soc, 2015; 4(4): 313-22. https://doi.org/10.1093/jpids/piu074 DOI: https://doi.org/10.1093/jpids/piu074
Jaworski, R., et al., Fungal infections in children in the early postoperative period after cardiac surgery for congenital heart disease: a single-centre experience. Interact Cardiovasc Thorac Surg, 2016; 23(3): 431-7. https://doi.org/10.1093/icvts/ivw156 DOI: https://doi.org/10.1093/icvts/ivw156
Klingspor, L., et al., Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006-2008). Clin Microbiol Infect, 2015; 21(1): 87 e1-87 e10. https://doi.org/10.1016/j.cmi.2014.08.011 DOI: https://doi.org/10.1016/j.cmi.2014.08.011
Tragiannidis, A., et al., Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-alpha) inhibitors. Mycoses, 2017; 60(4): 222-229. https://doi.org/10.1111/myc.12576 DOI: https://doi.org/10.1111/myc.12576
Silva, M.F., et al., A Multicenter Study of Invasive Fungal Infections in Patients with Childhood-onset Systemic Lupus Erythematosus. J Rheumatol, 2015; 42(12): 2296-303. https://doi.org/10.3899/jrheum.150142 DOI: https://doi.org/10.3899/jrheum.150142
Jordan, I., et al., Per-species risk factors and predictors of invasive Candida infections in patients admitted to pediatric intensive care units: development of ERICAP scoring systems. Pediatr Infect Dis J, 2014; 33(8): e187-93. https://doi.org/10.1097/INF.0000000000000274 DOI: https://doi.org/10.1097/INF.0000000000000274
de Araujo Motta, F., et al., Risk Adjustment for Congenital Heart Surgery Score as a Risk Factor for Candidemia in Children Undergoing Congenital Heart Defect Surgery. Pediatr Infect Dis J, 2016; 35(11): 1194-1198. https://doi.org/10.1097/INF.0000000000001277 DOI: https://doi.org/10.1097/INF.0000000000001277
Schwartz, S., et al., Advances in the diagnosis and treatment of fungal infections of the CNS. Lancet Neurol, 2018; 17(4): 362-372. https://doi.org/10.1016/S1474-4422(18)30030-9 DOI: https://doi.org/10.1016/S1474-4422(18)30030-9
Pappas, P.G., et al., Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis, 2016; 62(4): 409-17. https://doi.org/10.1093/cid/civ1194 DOI: https://doi.org/10.1093/cid/civ1194
Calley, J.L. and A. Warris, Recognition and diagnosis of invasive fungal infections in neonates. J Infect, 2017; 74 Suppl 1: S108-S113. https://doi.org/10.1016/S0163-4453(17)30200-1 DOI: https://doi.org/10.1016/S0163-4453(17)30200-1
Faix, R.G., Systemic Candida infections in infants in intensive care nurseries: high incidence of central nervous system involvement. J Pediatr, 1984; 105(4): 616-22. https://doi.org/10.1016/S0022-3476(84)80433-3 DOI: https://doi.org/10.1016/S0022-3476(84)80433-3
Baley, J.E. and R.A. Silverman, Systemic candidiasis: cutaneous manifestations in low birth weight infants. Pediatrics, 1988; 82(2): 211-5. https://doi.org/10.1542/peds.82.2.211 DOI: https://doi.org/10.1542/peds.82.2.211
Yao, Y., et al., Voriconazole: a novel treatment option for cryptococcal meningitis. Infect Dis (Lond), 2015; 47(10): 694-700. https://doi.org/10.3109/23744235.2015.1044260 DOI: https://doi.org/10.3109/23744235.2015.1044260
Martin, J.M., et al., Safety, Efficacy, and Exposure-Response of Voriconazole in Pediatric Patients With Invasive Aspergillosis, Invasive Candidiasis or Esophageal Candidiasis. Pediatr Infect Dis J, 2017; 36(1): e1-e13. https://doi.org/10.1097/INF.0000000000001339 DOI: https://doi.org/10.1097/INF.0000000000001339
Chen, K., et al., Individualized Medication of Voriconazole: A Practice Guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society. Ther Drug Monit, 2018; 40(6): 663-674. https://doi.org/10.1097/FTD.0000000000000561 DOI: https://doi.org/10.1097/FTD.0000000000000561
Stott, K.E. and W. Hope, Pharmacokinetics-pharmacodynamics of antifungal agents in the central nervous system. Expert Opin Drug Metab Toxicol, 2018; 14(8): 803-815. https://doi.org/10.1080/17425255.2018.1492551 DOI: https://doi.org/10.1080/17425255.2018.1492551
Lutsar, I., S. Roffey, and P. Troke, Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients. Clin Infect Dis, 2003; 37(5): 728-32. https://doi.org/10.1086/377131 DOI: https://doi.org/10.1086/377131
Bartelink, I.H., et al., Highly variable plasma concentrations of voriconazole in pediatric hematopoietic stem cell transplantation patients. Antimicrob Agents Chemother, 2013; 57(1): 235-40. https://doi.org/10.1128/AAC.01540-12 DOI: https://doi.org/10.1128/AAC.01540-12
Yamada, T., et al., Saturated Metabolism of Voriconazole N-Oxidation Resulting in Nonlinearity of Pharmacokinetics of Voriconazole at Clinical Doses. Biol Pharm Bull, 2015; 38(10): 1496-503. https://doi.org/10.1248/bpb.b15-00241 DOI: https://doi.org/10.1248/bpb.b15-00241
Michael, C., et al., Voriconazole pharmacokinetics and safety in immunocompromised children compared to adult patients. Antimicrob Agents Chemother, 2010; 54(8): 3225-32. https://doi.org/10.1128/AAC.01731-09 DOI: https://doi.org/10.1128/AAC.01731-09
Spriet, I., et al., Voriconazole plasma levels in children are highly variable. Eur J Clin Microbiol Infect Dis, 2011; 30(2): 283-7. https://doi.org/10.1007/s10096-010-1079-8 DOI: https://doi.org/10.1007/s10096-010-1079-8
Al Jalali, V., et al., In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid. Infection, 2019; 47(4): 565-570. https://doi.org/10.1007/s15010-019-01275-9 DOI: https://doi.org/10.1007/s15010-019-01275-9
Li, S.S., et al., Voriconazole combined with low-dose amphotericin B liposome for treatment of cryptococcal meningitis. Infect Dis (Lond), 2016; 48(7): 563-5. https://doi.org/10.3109/23744235.2016.1157897 DOI: https://doi.org/10.3109/23744235.2016.1157897
Groll, A.H., et al., Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J Infect Dis, 2000; 182(1): 274-82. https://doi.org/10.1086/315643 DOI: https://doi.org/10.1086/315643
